Abstract 875: Next generation clonal neoantigen targeting T cells, generated using the PELEUSTM bioinformatics platform and the VELOSTM manufacturing method show superior reactivity and phenotypic characteristics than classical TIL productsEleni Kotsiou, Katy Newton, Joseph Robinson et al.|Cancer Research|2020Cited by 3